Long-term glucocorticoid exposure persistently impairs CD4+ T cell biology by epigenetically modulating the mTORC1 pathway
Authors:
- 15 March 2023
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 211, 115503
Abstract
No abstract availableKeywords
Funding Information
- Xiangya Hospital, Central South University
- National Natural Science Foundation of China (81770691, 81970804, 82170759)
This publication has 40 references indexed in Scilit:
- Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case–control analysisAnnals of the Rheumatic Diseases, 2012
- Regulation and function of mTOR signalling in T cell fate decisionsNature Reviews Immunology, 2012
- Rapamycin Ameliorates Kidney Fibrosis by Inhibiting the Activation of mTOR Signaling in Interstitial Macrophages and MyofibroblastsPLOS ONE, 2012
- An Oscillatory Switch in mTOR Kinase Activity Sets Regulatory T Cell ResponsivenessImmunity, 2010
- Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription FactorImmunity, 2009
- The mTOR Kinase Differentially Regulates Effector and Regulatory T Cell Lineage CommitmentImmunity, 2009
- Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte traffickingNature Immunology, 2008
- Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genomeNature Genetics, 2007
- Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cellsNature Genetics, 2005
- Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cellsBlood, 2005